Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance. | Haematologica | 2022 | 35081690 | PubTator, text mining | PubMed |
| Time-Resolved Gene Expression Analysis Monitors the Regulation of Inflammatory Mediators and Attenuation of Adaptive Immune Response by Vitamin D. | Int J Mol Sci | 2022 | 35055093 | PubTator, text mining | PubMed |
| The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma. | Life (Basel) | 2022 | 35054466 | PubTator, text mining | PubMed |
| Decoding the role of macrophages in periodontitis and type 2 diabetes using single-cell RNA-sequencing. | FASEB J | 2022 | 35032412 | PubTator, text mining | PubMed |
| Cytoplasmic RNA sensors and their interplay with RNA-binding partners in innate antiviral response: theme and variations. | RNA | 2022 | 35031583 | PubTator, text mining | PubMed |
| Inflammation-scores as prognostic markers of overall survival in lung cancer: a register-based study of 6,210 Danish lung cancer patients. | BMC Cancer | 2022 | 35027001 | PubTator, text mining | PubMed |
| The follicular lymphoma epigenome regulates its microenvironment. | J Exp Clin Cancer Res | 2022 | 35022084 | PubTator, text mining | PubMed |
| Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. | Cell | 2022 | 35021064 | PubTator, text mining | PubMed |
| Evaluation of a gene expression biomarker to identify operationally tolerant liver transplant recipients: the LITMUS trial. | Clin Exp Immunol | 2022 | 35020854 | PubTator, text mining | PubMed |
| RegEnrich gene regulator enrichment analysis reveals a key role of the ETS transcription factor family in interferon signaling. | Commun Biol | 2022 | 35017649 | PubTator, text mining | PubMed |
| Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma. | Blood Adv | 2022 | 35015819 | PubTator, text mining | PubMed |
| Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions. | Nat Commun | 2022 | 35013316 | PubTator, text mining | PubMed |
| Insights into Modern Therapeutic Approaches in Pediatric Acute Leukemias. | Cells | 2022 | 35011701 | PubTator, text mining | PubMed |
| Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells. | iScience | 2022 | 35005550 | PubTator, text mining | PubMed |
| Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. | Oncoimmunology | 2022 | 35003900 | PubTator, text mining | PubMed |
| Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer. | Oncoimmunology | 2022 | 35003898 | PubTator, text mining | PubMed |
| The role of inflammasomes in vascular cognitive impairment. | Mol Neurodegener | 2022 | 35000611 | PubTator, text mining | PubMed |
| Engineering of human mesenchymal stem cells resistant to multiple natural killer subtypes. | Int J Biol Sci | 2022 | 34975342 | PubTator, text mining | PubMed |
| Genomic Characterization of De Novo Metastatic Breast Cancer. | Clin Breast Cancer | 2022 | 34949553 | PubTator, text mining | PubMed |
| Human NLRP1: From the shadows to center stage. | J Exp Med | 2022 | 34910085 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=46